by Cal Strode | Mar 29, 2023
Few people have made bigger contributions to the Canadian regenerative medicine ecosystem than Dr. Peter Zandstra. He is co-founder of two companies advancing cutting-edge biotechnologies for therapeutic use (Notch Therapeutics and ExCellThera, both of which are...
by Stacey Johnson | Feb 11, 2023
Have you heard of Henrietta Leavitt, Annie Cannon and Williamina Fleming? They are to astronomy what Katherine Johnson, Dorothy Vaughan and Mary Jackson are to NASA and the space race. If the latter three names are familiar, you probably saw the movie Hidden Figures,...
by Stacey Johnson | Jan 27, 2023
Last year saw the organizers behind Advanced Therapies Week (ATW) move the conference from Miami to Miami Beach to accommodate a larger audience. As the Covid-19 pandemic was still going strong in January 2022, making international travel more difficult, attendance...
by Cal Strode | Jan 12, 2023
The Alliance for Regenerative Medicine (ARM) delivered its State of the Industry Briefing (#CGSOTI23) at Biotech Showcase, held January 9–11, 2023, in San Francisco, California. Tim Hunt, CEO, of the Alliance for Regenerative Medicine (ARM) kicked things off by...
by Cal Strode | Jan 5, 2023
In 2022, the UK’s Cell and Gene Therapy Catapult (aka CGT Catapult) celebrated its tenth anniversary (congratulations!) marking 10 years of accelerating innovation in cell and gene therapies (CGTs) in the UK. Much like CCRM, CGT Catapult was established as an...
by Stacey Johnson | Dec 23, 2022
Having written several “my favourite blog posts” over the years, I decided to turn this very important responsibility over to my communications colleagues at CCRM. I asked Cal Strode and Tannen Horber, who are both contributors and have bios on the site, to pick their...
Comments